#United States #New York #Semler Scientific #Faruqi & Faruqi #SMLR

Faruqi & Faruqi Investigates Semler Scientific Inc.

In a recent announcement, Faruqi & Faruqi, LLP, a leading national securities law firm, has launched an investigation into potential claims against Semler Scientific, Inc. (NASDAQ: SMLR). This inquiry is primarily aimed at helping investors who believe they may have incurred losses due to associated events affecting the company. The firm is reaching out to those who experienced financial losses between March 10, 2021, and April 15, 2025, encouraging them to discuss their legal options.

Faruqi & Faruqi's Senior Partner James (Josh) Wilson is at the forefront of this investigation. He has urged investors who may be eligible for compensation to contact him directly. Interested parties can reach him at 877-247-4292 or through his extension at 212-983-9330 (Ext. 1310). Along with this personal outreach, the firm has set a crucial deadline of October 28, 2025, for potential lead plaintiffs in a federal securities class action against Semler Scientific.

The backdrop of this investigation stems from allegations that Semler Scientific, along with its executives, may have violated federal securities laws. The firm asserts that the company failed to disclose significant information regarding a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act. It is alleged that this omission misled investors regarding the true nature of the company’s standing and potential liabilities.

The implications of these claims became evident following the company's submission of its 2024 annual report to the SEC on February 28, 2025. In this report, Semler disclosed that initial discussions with the DOJ regarding potential settlements had begun but were halted on the same day. This delay heightened fears that a formal complaint could soon follow from the DOJ, which in turn, would materially affect the company's financial outlook. Following this news, Semler Scientific’s stock plummeted by over 9% in the subsequent trading session.

Being appointed as a lead plaintiff is significant because it allows the investor with the largest financial stake in the relief sought to guide the litigation on behalf of their fellow class members. However, it's important to note that choosing not to pursue this role does not affect one's ability to participate in any recovery from the lawsuit.

Faruqi & Faruqi encourages anyone with insights related to Semler Scientific's actions, including whistleblowers, former employees, and shareholders, to come forward. The firm is particularly interested in gathering diverse perspectives that could strengthen the case against the company.

For those seeking to learn more about the developing class action suit against Semler Scientific, resources and information are available on the firm’s website. Interested individuals can visit www.faruqilaw.com/SMLR or contact Josh Wilson directly to discuss their situation in detail.

In a landscape where investment trusts can be considerably affected by corporate missteps and lack of transparency, the ongoing investigation into Semler Scientific serves as a vital reminder of the importance of due diligence and the rights of investors. As the situation unfolds, all eyes will be on the responses from Semler and the legal developments surrounding this case, which may set precedents for future securities litigation.

Faruqi & Faruqi has earned a reputation for its success in recovering significant funds for investors since its founding in 1995, and they remain committed to standing up for the rights of the investing public. As always, the firm assures all communications will remain confidential, welcoming discussions with anyone impacted by the recent revelations regarding Semler Scientific.